Article info
PDFInflammatory bowel disease
Original article
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
- Correspondence to Dr Gert Van Assche, Division of Gastroenterology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium; gert.vanassche{at}uzleuven.be
Citation
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
Publication history
- Revised August 17, 2011
- Accepted August 28, 2011
- First published September 23, 2011.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.